If achieved in individuals with PD, decreased CD4+ T cell traffic to the brain could protect dopaminergic neurons35 from an adaptive immune response directed against α-synuclein or other immunogenic neuron-derived antigen(s). This evidence concerns the gene SNCA and Parkinson disease.